Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study
- PMID: 39475968
- PMCID: PMC11524450
- DOI: 10.1371/journal.pone.0310457
Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study
Abstract
Objective: To describe the treatment outcomes of locally advanced cervical cancer managed with neoadjuvant chemotherapy (NACT) plus radical surgery at a gynecology oncology center in Ethiopia.
Methods: This was a retrospective descriptive study of management of locally advanced cervical cancer (LACC) at St. Paul's Hospital Millennium Medical College (Ethiopia) over 5 years. Data were collected by reviewing patient records. Data were analyzed using SPSS version 23. Simple descriptive analysis was employed to analyze clinical, histologic, and treatment outcomes of LACC managed with NACT+ radical surgery. Frequency and proportions were used to present the results' significance.
Results: A total of 98 patients were analyzed. One-third (31.6%) of cervical cancer patients with locally advanced disease were operable after neoadjuvant chemotherapy. Out of this, nodal metastasis was found in 2 patients (all pelvic lymph node metastasis). Disease recurrence within 2 years was 3% (1 recurrence within 6-12 months and 2 recurrences at 12-24 months).
Conclusion: This study supports utilization of NACT plus radical surgery for locally advanced cervical cancer, where chemoradiation is not readily available. Our findings imply that this treatment modality is a life-saving alternative treatment in a low-income setting, which is often married by shortage or unavailability of radiotherapy at the needed time before disease progression ensues.
Copyright: © 2024 Birara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.BMJ Open. 2023 May 30;13(5):e067767. doi: 10.1136/bmjopen-2022-067767. BMJ Open. 2023. PMID: 37253491 Free PMC article.
-
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.Eur J Surg Oncol. 2018 Jul;44(7):1062-1068. doi: 10.1016/j.ejso.2018.04.019. Epub 2018 May 3. Eur J Surg Oncol. 2018. PMID: 29753611 Clinical Trial.
-
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis.J Invest Surg. 2022 Feb;35(2):308-314. doi: 10.1080/08941939.2020.1856239. Epub 2020 Dec 8. J Invest Surg. 2022. PMID: 33289585
-
Exploring a conundrum: Evaluating the role of neoadjuvant chemotherapy preceding chemo-radiotherapy in locally advanced cervical cancer: A review article.Taiwan J Obstet Gynecol. 2025 Mar;64(2):219-229. doi: 10.1016/j.tjog.2024.10.013. Taiwan J Obstet Gynecol. 2025. PMID: 40049805 Review.
-
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.Anticancer Res. 2020 Sep;40(9):4819-4828. doi: 10.21873/anticanres.14485. Anticancer Res. 2020. PMID: 32878770 Review.